Accelerate Diagnostics reported 2.78M in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4933M 54M
Accelerate Diagnostics AXDX:US 2.78M 625K
Becton, Dickinson and BDX:US $ 2574M 132M
Bio Rad Laboratories BIO:US $ 295.12M 1.38M
Bruker BRKR:US $ 290.2M 1.5M
Danaher DHR:US $ 3030M 47M
Exact Sciences EXAS:US $ 144.6M 9.9M
Hologic HOLX:US $ 443.7M 45.4M
Illumina ILMN:US $ 395M 13M
Meridian Bioscience VIVO:US $ 31.04M 11.71M
Myriad Genetics MYGN:US $ 49.7M 1.7M
Nanostring Technologies NSTG:US $ 15.85M 1.07M
Pacific Biosciences Of California PACB:US $ 19.27M 0.26M
Perkinelmer PKI:US $ 563.41M 16.8M
Thermo Fisher Scientific TMO:US $ 6240M 114M